4//SEC Filing
Nexvet Biopharma plc 4
Accession 0001572426-16-000222
CIK 0001618561operating
Filed
Sep 6, 8:00 PM ET
Accepted
Sep 7, 5:37 PM ET
Size
5.6 KB
Accession
0001572426-16-000222
Insider Transaction Report
Form 4
Heffernan Mark
Chief Executive Officer
Transactions
- Exercise/Conversion
Restricted Share Units
2016-09-05+142,572→ 142,572 totalExercise: $0.13Exp: 2021-07-01→ Ordinary Shares (142,572 underlying)
Footnotes (1)
- [F1]35,643 of the Restricted Share Units shall vest and become convertible on each of 7/1/17, 7/1/18, 7/1/19 and 7/1/20, in each case subject to payment of the nominal value per share to Issuer within 30 days of vesting.
Documents
Issuer
Nexvet Biopharma plc
CIK 0001618561
Entity typeoperating
IncorporatedIreland
Related Parties
1- filerCIK 0001618561
Filing Metadata
- Form type
- 4
- Filed
- Sep 6, 8:00 PM ET
- Accepted
- Sep 7, 5:37 PM ET
- Size
- 5.6 KB